Atlas Trials

Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder

Clinical trial NCT01382706 · TERMINATED

Trial details

NCT number
NCT01382706
Sponsor
University of Southern California
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Bladder CancerStage III Bladder CancerStage IV Bladder CancerTransitional Cell Carcinoma of the Bladder
Start date
2011-06-13
Primary completion
2013-07-15
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.